123 employees
Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.
1996
$30M
from 1 investors over 1 rounds
Xenon Pharmaceuticals Inc. raised $30M on December 2, 2019
Investors: Neurocrine Biosciences